Exercise of Options

Summary by AI BETAClose X

Xaar plc announced the exercise of 3,041 options under its Sharesave Plan on July 8th and 16th, 2026, resulting in the issuance of 3,041 new ordinary shares. These new shares are expected to be admitted to trading on the Official List on September 8th, 2026. The total number of shares in issue remains unchanged at 79,822,969, with the total voting rights also remaining at 79,822,969 ordinary shares, which shareholders can use as the denominator for regulatory notification calculations.

Disclaimer*

Xaar PLC
04 September 2026
 

 

 

4 September 2026

 

Xaar plc

(LSE: XAR)

 ("Xaar", or "the Company", or "the Group")

Exercise of Options

Xaar plc (LSE: XAR), the leading inkjet printing technology group, announces that on the 8th and 16th July 2026 a total of 3,041 options were exercised under the Xaar Sharesave Plan, which the Company satisfied by the issue of 3,041 new ordinary shares in the Company.

Application has been made to the London Stock Exchange for the admission to trading of the 3,041 new ordinary shares on the Official List. It is expected that admission will become effective at 8.00am on 8 September 2026.

As 2,109 new ordinary shares and 932 new ordinary shares were allotted and issued on 8th July 2026 and 16th July 2026 respectively, the Company confirms that the number of shares in issue remains at 79,822,969. Therefore the number of total voting rights remain at 79,822,969 ordinary shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Xaar plc under the FCA's Disclosure and Transparency Rules.

Enquiries:         

The person responsible for making this announcement is Lydia Harratt, Deputy Company Secretary, Xaar plc: investor.relations@xaar.com

Xaar plc's LEI code is 213800MXEC3KAOBBPO57

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Xaar (XAR)
UK 100

Latest directors dealings